Biosimilars Activities
Increasing Access to Diabetes Care Through Insulin Biosimilars
0290-0000-20-069-H01-P
This activity will highlight direct and indirect costs of diabetes in the United States today and the potential effects of and barriers to biosimilar insulin.
1.00
.jpg)
An American Journal of Managed Care Supplement: Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer
0290-0000-20-062-H03-P
This supplement will identify challenges to evidence-based adoption of trastuzumab biosimilars and other HER2-targeted therapies.
2.00